default search action

combined dblp search
author search
venue search
publication search

ask others

Tobias Kolditz

> Home > Persons

Person information

SPARQL queries

run query for this person

or build your own?

Refine list

refinements active!

zoomed in on ?? of ?? records

view refined list in

export refined list as

showing all ?? records

2020 – today

see FAQ

What is the meaning of the colors in the publication lists?

2020
[c3]
- view
  - electronic edition via DOI (open access)
  - details & citations
  authority control:
- export record
  dblp key:
  - conf/mie/LohrMHKH20
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/mie/LohrMHKH20
Christina Lohr, Luise Modersohn, Johannes Hellrich, Tobias Kolditz, Udo Hahn:
An Evolutionary Approach to the Annotation of Discharge Summaries. MIE 2020: 28-32

2010 – 2019

see FAQ

What is the meaning of the colors in the publication lists?

2019
[c2]
- view
  authority control:
- export record
  dblp key:
  - conf/acllaw/LohrKLHKSH19
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/acllaw/LohrKLHKSH19
Christina Lohr, Johannes Kiesel, Stephanie Luther, Johannes Hellrich, Tobias Kolditz, Benno Stein, Udo Hahn:
Continuous Quality Control and Advanced Text Segment Annotation with WAT-SL 2.0. LAW@ACL 2019: 215-219
[c1]
- view
  - electronic edition via DOI (open access)
  - details & citations
  authority control:
- export record
  dblp key:
  - conf/medinfo/KolditzLHMBKH19
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/medinfo/KolditzLHMBKH19
Tobias Kolditz, Christina Lohr, Johannes Hellrich, Luise Modersohn, Boris Betz, Michael Kiehntopf, Udo Hahn:
Annotating German Clinical Documents for De-Identification. MedInfo 2019: 203-207

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.